HUNTLEY, Ill.--(BUSINESS WIRE)--Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today the first surgical cases of ARx...
WARSAW, Ind., Jan. 06, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the establishment of...
The European Innovation Council (EIC) Fund, through the EIC Accelerator Program, and Cap Horn join existing pool of strategic investors. Bpifrance, the French national investment bank, adds €1 M debt financing...
Deal Strengthens Zimmer Biomet's Growing Sports Medicine Portfolio and Supports Continued Company Transformation WARSAW, Ind., Jan. 5, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader,...
STOCKHOLM, SWEDEN, January 4, 2023. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company OssDsign has published the first case report on a patient that underwent spinal fusion...
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ: OFIX) and SeaSpine Holdings Corporation today announced the successful completion of their previously announced merger of equals following the approval of each company’s stockholders at respective...
TAMPERE, Finland, Jan. 4, 2023 /PRNewswire/ -- Bioretec Ltd, a pioneer in bioresorbable orthopedic implants, has finalized the supplement for market authorization request in accordance with the De Novo registration process concerning...
CARLSBAD, Calif., Dec. 27, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced...
BBS-Bioactive Bone Substitutes, Company announcement, Insider information, 30 December 2022 at 2:00 p.m. BBS updates estimate of the CE marking approval schedule of ARTEBONE® Paste In March 2022, BBS-Bioactive Bone Substitutes Plc ("BBS") submitted a CE...
ATLANTA, Dec. 23, 2022 /PRNewswire/ -- Lipogems, a clinical stage- global medical technology company that utilizes autologous adipose tissue for therapeutic use in orthopaedics and other specialties today announces it has raised €12.5M...